Leadership & Pay ·
Paul V. Goode resigns from Glucotack board citing potential conflict of interest with Lokahi Therapeutics merger
GCTKGlucotrack, Inc.
On September 14, 2026, Paul V. Goode resigned from the Board of Directors of Glucotrack, Inc., effective immediately. Mr. Goode cited a potential conflict of interest between the Company and its subsidiary regarding ongoing discussions about implementing duties under the merger agreement for the business combination with Lokahi Therapeutics, Inc. The Company has provided Mr. Goode an opportunity to submit a letter agreeing or disagreeing with these statements, which will be filed as an exhibit if received. Glucotrack, Inc. operates in the healthcare technology industry, developing digital health solutions.